W Birkmayer, E Neumayer. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Antiparkinson Agents/therapeutic useBrain Stem/analysisDihydroxyphenylalanine/adverse effectsDihydroxyphenylalanine/therapeutic useDopamine/analysisDrug SynergismFemaleGastrointestinal Diseases/chemically inducedHumansHydrazines/therapeutic useHydroxyindoleacetic Acid/cerebrospinal fluidMaleMovement Disorders/chemically inducedNorepinephrine/analysisParkinson Disease/drug therapyPsychoses, Substance-Induced/drug therapyPsychoses, Substance-Induced/etiologySerotonin/analysisTryptophan/therapeutic use
Substances: See more » Antiparkinson AgentsHydrazinesSerotoninHydroxyindoleacetic AcidDihydroxyphenylalanineTryptophanDopamineNorepinephrine
Year: 1972 PMID: 4117647
Source DB: PubMed Journal: Z Neurol ISSN: 0012-1037